The complaint claims that the state illegally changed rules regarding income eligibility thresholds for the AIDS Drug ...

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but these celebrations were tempered by insurers’ reluctance to cover its ...

Scientists say research into a vaccine for HIV is further along than it’s ever been.But Trump administration cuts to ...

This session examines the current state of progress toward a functional cure for HIV, drawing on advances in immunology, ...

The tool can be used to find providers that offer HIV testing and medications that prevent the virus, which causes AIDS.

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it looked as if it would be over before it started.

Andrew Spieldenner, executive director of MPACT Global, is one of The Advocate's 2026 Amazing People with HIV.

BEAVERTON, OR, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Sedia Biosciences Corporation, a leading developer ...

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.